Kudo Mikihiko, Yozu Ryohei
Department of Cardiovascular Surgery, Keio University School of Medicine, 35 Shinano-machi, Shinjuku-ku, Tokyo, 160-8582, Japan,
Gen Thorac Cardiovasc Surg. 2014 Jun;62(6):342-50. doi: 10.1007/s11748-014-0398-6. Epub 2014 Apr 11.
Following the revision of the therapeutic guideline of ACC/AHA in (Circulation 114:450-527, 2006), the incidence of mitral valve repair in asymptomatic patients with moderate or severe mitral valve regurgitation has increased. For mitral valve repair, the quality and outcomes as well as lower invasive procedure are important to obtain the confidence of cardiologists and ensure request of early phase operation from cardiologists. With recent innovations of technologies and the development of revolutionary techniques, minimally invasive surgery of the mitral valve (MIS-MV) has become a widespread surgical option of mitral valve repair. It is vital, however, that careful preoperative assessment, and planning of the approach and perfusion strategy are put in place to perform MIS-MV safely.
随着美国心脏病学会/美国心脏协会（ACC/AHA）治疗指南于2006年修订（《循环》114:450 - 527），无症状的中重度二尖瓣反流患者二尖瓣修复术的发生率有所增加。对于二尖瓣修复术而言，手术质量、效果以及较低的侵入性操作对于赢得心脏病专家的信任并确保他们提出早期手术要求至关重要。随着近期技术创新以及革命性技术的发展，二尖瓣微创手术（MIS - MV）已成为二尖瓣修复术广泛采用的手术方式。然而，至关重要的是，要进行仔细的术前评估，并制定手术入路和灌注策略，以安全地实施二尖瓣微创手术。
